Tradename information - 51491000087100
View tradename immunizing agents subset
Concept details
[COVID-19] NUVAXOVID Omicron XBB.1.5
Pan-Canadian SNOMED CT terminology
- Concept code
- 51491000087100
- Concept status
- active
- Version
- 20230930
- Display name
- English: [COVID-19] NUVAXOVID Omicron XBB.1.5
- French: [COVID-19] NUVAXOVID Omicron XBB.1.5
- Abbreviation
- English: COVID-19
- French: COVID-19
- Fully specified name
- NUVAXOVID Omicron XBB.1.5 recombinant spike protein 5 micrograms per 0.5 milliliter suspension for injection Novavax Inc. (real clinical drug)
- Market authorization holder
- NOVAVAX INC.
Health Canada drug information
Select the DIN below to go directly to the product monograph on the Health Canada website
| Drug Identification Number | Product status | Strength | Typical dose |
|---|---|---|---|
| 02543656 | Marketed | 5 MCG | 0.5 ML |
Linked product data
Lot numbers
Linked concepts
Linked generic concepts:
This vaccine protects against the following diseases:
This vaccine contains the following antigens:
National Vaccine Catalogue database details
- Last updated
- 2025-03-06
Concept history
This concept replaces
| Concept code | Display name |
|---|---|
| No data is available | |
Notice
Some information normally contained in the National Vaccine Catalogue may be unavailable due to ongoing mapping updates or because the source data did not provide the information, and in some cases, the information field is blank as it may not be applicable in the given context. The information contained in the National Vaccine Catalogue may also be subject to change following data reconciliation.
Disclaimer
The use of the standard SNOMED CT terminology and codes is subject to your annual acceptance of both the SNOMED CT® Affiliate License Agreement and the SNOMED CT® Canadian National License Agreement. To acknowledge and accept these agreements, register an account on Canada Health Infoway. For additional information on the agreements, please visit Canada Health Infoway.
- Version:
- 1.0.12